Correlation Between Imricor Medical and Elevate Uranium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Imricor Medical and Elevate Uranium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Imricor Medical and Elevate Uranium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Imricor Medical Systems and Elevate Uranium, you can compare the effects of market volatilities on Imricor Medical and Elevate Uranium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Imricor Medical with a short position of Elevate Uranium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Imricor Medical and Elevate Uranium.

Diversification Opportunities for Imricor Medical and Elevate Uranium

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Imricor and Elevate is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Imricor Medical Systems and Elevate Uranium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevate Uranium and Imricor Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Imricor Medical Systems are associated (or correlated) with Elevate Uranium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevate Uranium has no effect on the direction of Imricor Medical i.e., Imricor Medical and Elevate Uranium go up and down completely randomly.

Pair Corralation between Imricor Medical and Elevate Uranium

Assuming the 90 days trading horizon Imricor Medical Systems is expected to generate 1.14 times more return on investment than Elevate Uranium. However, Imricor Medical is 1.14 times more volatile than Elevate Uranium. It trades about 0.07 of its potential returns per unit of risk. Elevate Uranium is currently generating about 0.02 per unit of risk. If you would invest  39.00  in Imricor Medical Systems on September 2, 2024 and sell it today you would earn a total of  77.00  from holding Imricor Medical Systems or generate 197.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Imricor Medical Systems  vs.  Elevate Uranium

 Performance 
       Timeline  
Imricor Medical Systems 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Imricor Medical Systems are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Imricor Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.
Elevate Uranium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevate Uranium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Elevate Uranium is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Imricor Medical and Elevate Uranium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Imricor Medical and Elevate Uranium

The main advantage of trading using opposite Imricor Medical and Elevate Uranium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Imricor Medical position performs unexpectedly, Elevate Uranium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevate Uranium will offset losses from the drop in Elevate Uranium's long position.
The idea behind Imricor Medical Systems and Elevate Uranium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Managers
Screen money managers from public funds and ETFs managed around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency